JPRN-UMIN000012175已完成2 期
Phase II trial of Cisplatin and Irinotecan treatment as palliative-intended chemotherapy for previously untreated advanced thymic carcinoma - CDDP/CPT-11 for advanced thymic carcinoma
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital0 个研究点目标入组 0 人开始时间: 2013年11月30日最近更新:
适应症
试验速览
研究概览
简要总结
o patient was enrolled.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. With concurrent active cancer 2. Serious uncontrolled infections 3. With fever at more than 38 degree in Celicius 4. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 5. 6. 7. With malignant pleural, peritoneal effusion requiring drainage or pericardial effusion 6. With sever complication associated with operation 7. Under continuous steroid therapy 8. With uncontrolled diabetes melitus 9. With uncontrolled hypertension 10 Unstable angina or previous history of myocardial infarction within six months 11. With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray
研究者
相似试验
已完成
2 期
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryEsophageal CancerNCT00316862Alliance for Clinical Trials in Oncology82
已完成
2 期
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal JunctionGastric AdenocarcinomaStage II Gastric CancerStage III Gastric CancerStage IV Gastric CancerNCT00062374National Cancer Institute (NCI)55
已完成
2 期
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractGastrointestinal CancerCarcinoma, NeuroendocrineNCT00353015M.D. Anderson Cancer Center21
已完成
2 期
Irinotecan Study For Cervical CancerUterine Cervical NeoplasmsNCT00136955Pfizer41
终止
2 期
Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine CarcinomaNeuroendocrine CarcinomaNCT03168594Peking University66